We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$4.6B
AUM Growth
-$1.24B
Cap. Flow
-$1.38B
Cap. Flow %
-30.06%
Top 10 Hldgs %
46.62%
Holding
89
New
27
Increased
11
Reduced
16
Closed
25

Top Buys

Rank Stock Value
1
CRH icon
CRH
CRH
+$211M
2
WCC
WESCO International
WCC
+$172M
3
GEV icon
GE Vernova
GEV
+$135M
4
WDAY icon
Workday
WDAY
+$107M
5
KKR icon
KKR & Co
KKR
+$96.9M

Top Sells

Rank Stock Value
1
ARMK icon
Aramark
ARMK
+$178M
2
MSFT icon
Microsoft
MSFT
+$123M
3
FCX icon
Freeport-McMoran
FCX
+$112M
4
AVGO icon
Broadcom
AVGO
+$109M
5
ORCL icon
Oracle
ORCL
+$107M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.53%
2 Technology 17.01%
3 Materials 9.09%
4 Healthcare 9.01%
5 Industrials 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AA icon
26
Alcoa
AA
$11.3B
$68.4M 1.49%
1,718,203
-64,168
-4% -$2.48M
TECK icon
27
Teck Resources
TECK
$28.2B
$67.8M 1.47%
1,415,400
-50,051
-3% -$2.46M
APO icon
28
CALL
Apollo Global Management
APO
$69.6B
$59M 1.28%
500,000
DASH icon
29
DoorDash
DASH
$85B
$58.1M 1.26%
+533,988
New +$64.3M
XLE icon
30
CALL
State Street Energy Select Sector SPDR ETF
XLE
$39.1B
$54.7M 1.19%
+1,200,000
New +$55.9M
EXPE icon
31
CALL
Expedia Group
EXPE
$36.7B
$50.4M 1.1%
400,000
TMO icon
32
Thermo Fisher Scientific
TMO
$213B
$49.9M 1.08%
90,154
-18,178
-17% -$10.4M
LITE icon
33
Lumentum
LITE
$46.9B
$48.2M 1.05%
946,308
ROIV icon
34
Roivant Sciences
ROIV
$23.7B
$47.4M 1.03%
4,484,698
+438,213
+11% +$4.8M
AVGO icon
35
Broadcom
AVGO
$1.78T
$45.4M 0.99%
282,540
-777,210
-73% -$109M
TEVA icon
36
CALL
Teva Pharmaceuticals
TEVA
$39.1B
$40.6M 0.88%
+2,500,000
New +$38.5M
NTRA icon
37
Natera
NTRA
$35.7B
$40M 0.87%
+369,070
New +$37.5M
LITE icon
38
CALL
Lumentum
LITE
$46.9B
$38.2M 0.83%
+750,000
New +$34M
EQT icon
39
EQT Corp
EQT
$33B
$34.9M 0.76%
+944,407
New +$37M
EXE
40
Expand Energy Corp
EXE
$22.1B
$27M 0.59%
+328,871
New +$29M
MBB icon
41
iShares MBS ETF
MBB
$39.1B
$25.2M 0.55%
+274,678
New +$25M
AMGN icon
42
Amgen
AMGN
$210B
$19.8M 0.43%
+63,517
New +$18.7M
ULTA icon
43
Ulta Beauty
ULTA
$21.8B
$19.8M 0.43%
+51,310
New +$20.9M
BRBR icon
44
BellRing Brands
BRBR
$1.54B
$19.1M 0.42%
334,347
+168,068
+101% +$9.63M
MKSI icon
45
MKS Inc
MKSI
$17.7B
$19.1M 0.41%
146,204
ASML icon
46
ASML
ASML
$594B
$17.7M 0.38%
+17,302
New +$16.6M
BMA icon
47
Banco Macro
BMA
$5.75B
$15.5M 0.34%
+270,924
New +$15.5M
EVRG icon
48
Evergy
EVRG
$19.5B
$13.8M 0.3%
259,681
PAM icon
49
Pampa Energía
PAM
$4.53B
$13.7M 0.3%
309,429
-310,376
-50% -$14.2M
BBAR icon
50
BBVA Argentina
BBAR
$3.84B
$13.5M 0.29%
+1,458,494
New +$14.4M

Similar funds

PointState Capital's Q2 2024 Portfolio in Review

As of Q2 2024, PointState Capital held 89 positions worth $4.6B, down 21% from $5.84B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

PointState Capital withdrew a net $1.38B in Q2 2024, closing 25 positions and reducing 16 holdings. Its most notable exit was Oracle, an estimated $107M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 12% a quarter earlier, followed by Technology and Materials.

Against the trend, PointState Capital opened a new position in CRH worth $198M.

  • PointState Capital's largest Q2 2024 buy was CRH: 2,640,943 shares worth $198M.
  • PointState Capital added most to Workday in Q2 2024, an estimated $107M increase.
  • PointState Capital's biggest Q2 2024 reduction was Aramark, cutting an estimated $178M.
  • PointState Capital fully exited Oracle in Q2 2024, selling an estimated $107M.
  • PointState Capital's ten largest holdings make up 47% of its $4.6B portfolio in Q2 2024.
  • PointState Capital opened 27 new positions and closed 25 in Q2 2024.
  • PointState Capital's portfolio value fell 21% quarter-over-quarter to $4.6B.

Based on PointState Capital's 13F filing for Q2 2024, filed 14 Aug 2024.